feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Albino alligator Claude dies at 30

trending

College Football Playoff rankings reveal

trending

Duke defeats Florida, stays perfect

trending

Timberwolves edge Pelicans in OT

trending

Rupee crosses 90 against USD

trending

Thunder beat Warriors without Curry

trending

UConn defeats Kansas

trending

North Carolina defeats Kentucky

trending

USC Trojans defeat Oregon

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Ozempic for Paws? Pet Obesity Jab Trial Begins

Ozempic for Paws? Pet Obesity Jab Trial Begins

2 Dec

•

Summary

  • US pilot study tests GLP-1 drugs, similar to Ozempic, on cats.
  • Injectable implant aims to manage overweight cats and suppress hunger.
  • Potential cost under $100 monthly could save owners money.
Ozempic for Paws? Pet Obesity Jab Trial Begins

Pet obesity is a significant issue in countries like the US and UK, with estimates suggesting a majority of pets are overweight. Owners' perceptions of pet happiness tied to appetite contribute to this problem.

In response, a pilot study in the United States is now exploring GLP-1 drugs, a class including Ozempic and Wegovy, for use in cats. This research focuses on an injectable implant designed to manage feline weight by mimicking hormones that slow digestion and reduce hunger.

This innovative treatment, dubbed MEOW-1, could potentially cost owners less than $100 per month. This offers a more affordable alternative to current practices where veterinarians prescribe human-grade medications off-label at higher prices.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Yes, a pilot study is currently testing GLP-1 drugs, similar to Ozempic, on cats for weight management.
The company behind the trial hopes to keep the cost under $100 per month for the new injectable treatment.
MEOW-1 stands for 'ManagEment of Over Weight cats,' a pilot study testing a six-month injectable implant for feline weight loss.

Read more news on

Healthside-arrow

You may also like

Black Friday Power Bank Deals: Grab Yours Now!

24 Nov • 31 reads

article image

Brits Embrace AI Shopping Assistants as Automated Purchases Gain Mainstream Acceptance

17 Nov • 67 reads

article image

Cravings Spike as Temperatures Drop: The Science Behind Winter Appetites

15 Nov • 83 reads

article image

Rare Disease Breakthrough Denied: Family's Fight for Son's Life-Saving Treatment

11 Nov • 79 reads

article image

HYBE Suffers $30M Loss Despite Record Quarterly Revenue

11 Nov • 56 reads

article image